Latest Breaking News On - Crinetics pharmaceuticals - Page 9 : comparemela.com

Brokerages Set Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) PT at $54 00

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]

Richard scott struthersRobertw bairdDana pizzutiCrinetics pharmaceuticalsHedge funds weigh in on crinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailySecurities exchange commissionCrinetics pharmaceuticals tradingCrinetics pharmaceuticals incEventide asset managementAnalyst recommendations for crinetics pharmaceuticalsVanguard group incJennison associatesGet free reportScott struthersExchange commission

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Sees Significant Growth in Short Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 5,220,000 shares, a growth of 6.3% from the March 31st total of 4,910,000 shares. Based on an average trading volume of 802,900 shares, the days-to-cover ratio […]

Stephanie okeyRichard scott struthersRobertw bairdCrinetics pharmaceuticals incChina universal asset management coCrinetics pharmaceuticals stock performanceCantor fitzgeraldSecurities exchange commissionHighmark wealth managementInstitutional trading of crinetics pharmaceuticalsFisher asset managementHennion walsh asset management incCrinetics pharmaceuticalsInsider transactions at crinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailyMorgan stanley

Short Interest in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Rises By 6 3%

Short Interest in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Rises By 6 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dana pizzutiMarc wilsonInsider transactions at crinetics pharmaceuticalsCampbell co investment adviserCrinetics pharmaceuticals stockMorgan stanleyCrinetics pharmaceuticalsVictory capital management incCharles schwab investment management incNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals incSecurities exchange commissionSwiss national bankCrinetics pharmaceuticals company profileVivo capitalGet free report

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Natalie badilloCorey davisLifesci advisorsCrinetics pharmaceuticals to report first quarterHead of corporate communicationsCrinetics pharmaceuticals incCrinetics pharmaceuticalsReport first quarterSci advisors

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Sees Significant Growth in Short Interest

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Sees Significant Growth in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdRichard scott struthersStephanie okeyInsider transactions at crinetics pharmaceuticalsCrinetics pharmaceuticals incInstitutional trading of crinetics pharmaceuticalsCrinetics pharmaceuticals stock performanceChina universal asset management coNews ratings for crinetics pharmaceuticals dailySecurities exchange commissionCantor fitzgeraldFisher asset managementMorgan stanleyHighmark wealth managementCrinetics pharmaceuticalsHennion walsh asset management inc